Search

everythinglearnresearchcommunity

for

Search:↓

Researchers made a detailed map of gene activity for different parts of human hair follicles to help create targeted hair disorder treatments.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Cholesterol issues in skin and hair may cause permanent hair loss by triggering inflammation.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.

Certain inflammatory molecules and leptin may contribute to hair loss in cicatricial alopecia.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

TCM is an effective and safe treatment for primary cicatricial alopecias.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

Similar treatments might work for different types of scarring hair loss.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Potential therapeutic targets for scarring hair loss are identified.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Hair analysis can't determine ponies' calcium and phosphorus levels; use soil and feed tests instead.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Computational methods help design drugs targeting prostate cancer proteins.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

5-ARI therapy may help prevent prostate cancer progression.

ERG increases SOX9, promoting prostate cancer growth and invasion.